Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 116, Issue 35, Pages 17290-17297Publisher
NATL ACAD SCIENCES
DOI: 10.1073/pnas.1905516116
Keywords
second harmonic generation; KRAS; small G protein; cancer; small molecule inhibitors
Categories
Funding
- Office of The Director, NIH [S10OD023482]
- NIH/National Cancer Institute T32 Training Program Grant [T32 CA108462]
- Daiichi Sankyo
- National Cancer Institute, NIH [HHSN261200800001E]
Ask authors/readers for more resources
Second harmonic generation ( SHG) is an emergent biophysical method that sensitively measures real-time conformational change of biomolecules in the presence of biological ligands and small molecules. This study describes the successful implementation of SHG as a primary screening platform to identify fragment ligands to oncogenic Kirsten rat sarcoma ( KRas). KRas is the most frequently mutated driver of pancreatic, colon, and lung cancers; however, there are few well-characterized small molecule ligands due to a lack of deep binding pockets. Using SHG, we identified a fragment binder to KRas(G12D) and used H-1 N-15 transverse relaxation optimized spectroscopy ( TROSY) heteronuclear single-quantum coherence ( HSQC) NMR to characterize its binding site as a pocket adjacent to the switch 2 region. The unique sensitivity of SHG furthered our study by revealing distinct conformations induced by our hit fragment compared with 4,6-dichloro-2-methyl-3-aminoethyl-indole ( DCAI), a Ras ligand previously described to bind the same pocket. This study highlights SHG as a high-throughput screening platform that reveals structural insights in addition to ligand binding.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available